Acadian Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-49
Closed -$7K 2120
2018
Q4
$7K Buy
49
+3
+7% +$455 ﹤0.01% 1647
2018
Q3
$8K Sell
46
-481
-91% -$80.8K ﹤0.01% 1583
2018
Q2
$92K Sell
527
-908
-63% -$136K ﹤0.01% 1262
2018
Q1
$165K Buy
+1,435
New +$153K ﹤0.01% 1106

Other funds holding LOXO

Acadian Asset Management's LOXO Position: Q1 2019 in Review

Acadian Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 49 shares — an estimated $7K sold.

Acadian Asset Management first reported a position in LOXO in Q1 2018 and held it in 4 quarters. The position peaked at $165K in Q1 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Acadian Asset Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Acadian Asset Management sold 49 Loxo Oncology, Inc shares in Q1 2019, an estimated $7K.
  • Acadian Asset Management first reported a position in Loxo Oncology, Inc in Q1 2018 and held it in 4 quarters.
  • Acadian Asset Management's Loxo Oncology, Inc position peaked at $165K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Acadian Asset Management's 13F filing for Q1 2019, filed 9 May 2019.